Evidence map›Paper›PMID 39341469›Full record

ArticleToxicology in vitro : an international journal published in association with BIBRA2024

Evaluation of a New In Chemico Skin Corrosion Test.

Stewart Lebrun, Linda Nguyen, Kelly Vy Ho

Abstract read
In one paragraph

Article in Toxicology in vitro : an international journal published in association with BIBRA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stewart LebrunLebrun Labs LLC, 3301 E. Miraloma Ave., Ste. 194, Anaheim, CA 92806, USA. Electronic address: SJ@lebrunlabs.com.
Linda NguyenLebrun Labs LLC, 3301 E. Miraloma Ave., Ste. 194, Anaheim, CA 92806, USA.
Kelly Vy HoLebrun Labs LLC, 3301 E. Miraloma Ave., Ste. 194, Anaheim, CA 92806, USA.

Funding

An In Chemico Test to Identify Dermal CorrosivesR44ES036065 · NIEHS · LEBRUN LABS, LLC · PI Stewart Lebrun · 2024 to 2026
$2.0M
NIEHS NIH HHS R44 ES036065
6 · The paper itself

Abstract

The purpose of this study is to evaluate a novel macromolecular test method for the identification of dermal corrosives. The simple in chemico test procedure involves allowing the material to be tested to interact with a skin biomarker for corrosivity and then adding a detection reagent. The corrosivity of the test substance is predicted based on the measured macromolecular damage, which results in reduced optical density of the detection reagent as compared with controls. This study aims to determine if such an extremely simple, cell-free test method can accurately identify dermal corrosives. To determine predictivity and repeatability, we tested 60 chemicals (30 in vivo dermal corrosives and 30 in vivo dermal noncorrosives; all tested in triplicate) representative of a broad range of chemical classes, functional groups, mixtures, and levels of toxicity. Validation results indicate the GHS multicategory and packing group assignment accuracy is on par with that of the Reconstructed Human Epidermis test method and the Membrane Barrier test method and for the global identification of corrosives, the method has a considerably higher accuracy (98 % vs. ∼80 %).

Indexed as

CausticsAnimal Testing AlternativesHumansReproducibility of ResultsSkinSkin Irritancy TestsCausticsdermalGHSin chemicopacking groupsskin corrosion

Identifiers

PMID39341469
PMCPMC11737548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.